IL137727A0 - Pharmaceutical preparations for supplementing oestrogen deficiency - Google Patents

Pharmaceutical preparations for supplementing oestrogen deficiency

Info

Publication number
IL137727A0
IL137727A0 IL13772799A IL13772799A IL137727A0 IL 137727 A0 IL137727 A0 IL 137727A0 IL 13772799 A IL13772799 A IL 13772799A IL 13772799 A IL13772799 A IL 13772799A IL 137727 A0 IL137727 A0 IL 137727A0
Authority
IL
Israel
Prior art keywords
transcription
central nervous
oestrogen
estradiol
nervous system
Prior art date
Application number
IL13772799A
Other languages
English (en)
Original Assignee
Jenapharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1998121831 external-priority patent/DE19821831A1/de
Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh
Publication of IL137727A0 publication Critical patent/IL137727A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
IL13772799A 1998-02-20 1999-02-10 Pharmaceutical preparations for supplementing oestrogen deficiency IL137727A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19807264 1998-02-20
DE1998121831 DE19821831A1 (de) 1998-05-15 1998-05-15 Pharmazeutische Präparate zur gezielten Substitution des Estrogenmangels im Zentralnervensystem
PCT/DE1999/000353 WO1999042108A1 (de) 1998-02-20 1999-02-10 Pharmazeutische präparate zur gezielten substitution des estrogenmangels im zentralnervensystem

Publications (1)

Publication Number Publication Date
IL137727A0 true IL137727A0 (en) 2001-10-31

Family

ID=26044035

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13772799A IL137727A0 (en) 1998-02-20 1999-02-10 Pharmaceutical preparations for supplementing oestrogen deficiency

Country Status (24)

Country Link
EP (1) EP1056460B1 (xx)
JP (1) JP2002503694A (xx)
KR (1) KR20010041107A (xx)
CN (1) CN1291102A (xx)
AT (1) ATE252388T1 (xx)
AU (1) AU739071C (xx)
BG (1) BG104689A (xx)
BR (1) BR9909205A (xx)
CA (1) CA2321498A1 (xx)
CZ (1) CZ291764B6 (xx)
DE (1) DE59907446D1 (xx)
EA (1) EA002707B1 (xx)
EE (1) EE03906B1 (xx)
HU (1) HUP0100742A3 (xx)
ID (1) ID27069A (xx)
IL (1) IL137727A0 (xx)
IS (1) IS5571A (xx)
NO (1) NO20004153L (xx)
NZ (1) NZ506049A (xx)
PL (1) PL342313A1 (xx)
SK (1) SK12152000A3 (xx)
TR (1) TR200002400T2 (xx)
UA (1) UA57830C2 (xx)
WO (1) WO1999042108A1 (xx)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2253318T3 (es) 2001-11-07 2006-06-01 Schering Ag Cribado in vitro de ligandos del receptor de estrogeno.
CN112189624A (zh) * 2020-09-08 2021-01-08 山东第一医科大学(山东省医学科学院) 一种利用受体基因沉默技术构建和鉴定女性ad模型的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791099A (en) * 1984-10-29 1988-12-13 Chaovanee Aroonsakul Method of treatment for central nervous system diseases such as Alzheimer's's disease
US4897389A (en) * 1984-10-29 1990-01-30 Chaovanee Aroonsakul Treating central nervous system diseases
DE4239946C2 (de) * 1992-11-27 2001-09-13 Jenapharm Gmbh Estranderivate mit einer 14alpha,15alpha-Methylengruppe und Verfahren zu ihrer Herstellung
US5554601A (en) * 1993-11-05 1996-09-10 University Of Florida Methods for neuroprotection
DE4338314C1 (de) * 1993-11-10 1995-03-30 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen
DE4429397C2 (de) * 1994-08-09 2003-11-20 Jenapharm Gmbh Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
DE19524937A1 (de) * 1995-07-08 1997-01-09 Jenapharm Gmbh Pharmazeutische Präparate zur Prophylaxe und Therapie radikalvermittelter Zellschädigungen und zur medikamentösen Substitution beim Mann
JPH11510144A (ja) * 1995-07-24 1999-09-07 ユニバーシティー・オブ・フロリダ・リサーチ・ファンデーション・インコーポレーテッド 細胞に神経保護を付与するための薬剤の製造のための非エストロゲン多環式フェノール化合物の使用

Also Published As

Publication number Publication date
SK12152000A3 (sk) 2001-02-12
CN1291102A (zh) 2001-04-11
AU739071C (en) 2002-04-11
EP1056460A1 (de) 2000-12-06
JP2002503694A (ja) 2002-02-05
IS5571A (is) 2000-07-24
BG104689A (en) 2001-04-30
UA57830C2 (uk) 2003-07-15
NO20004153D0 (no) 2000-08-18
HUP0100742A2 (hu) 2001-09-28
TR200002400T2 (tr) 2000-11-21
PL342313A1 (en) 2001-06-04
ATE252388T1 (de) 2003-11-15
KR20010041107A (ko) 2001-05-15
NZ506049A (en) 2002-09-27
BR9909205A (pt) 2000-11-14
EP1056460B1 (de) 2003-10-22
NO20004153L (no) 2000-10-09
HUP0100742A3 (en) 2002-07-29
EE03906B1 (et) 2002-12-16
DE59907446D1 (de) 2003-11-27
EA002707B1 (ru) 2002-08-29
EA200000858A1 (ru) 2001-04-23
CZ291764B6 (cs) 2003-05-14
AU739071B2 (en) 2001-10-04
EE200000477A (et) 2001-12-17
AU2920999A (en) 1999-09-06
CZ20002938A3 (cs) 2001-01-17
ID27069A (id) 2001-02-22
CA2321498A1 (en) 1999-08-26
WO1999042108A1 (de) 1999-08-26

Similar Documents

Publication Publication Date Title
WO1998027929A3 (de) Therapeutische gestagene zur behandlung von premenstrual dysphoric disorder
WO1996019568A3 (en) Stabilized ribozyme analogs
HUP0102483A2 (hu) Androszt-5-én-3béta, 17béta-diolt tartalmazó gyógyszerkészítmények
MX9700223A (es) Composicion farmaceutica para la liberacion controlada de moguisteina en una suspension liquida.
AU2561195A (en) Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
IL108234A0 (en) Pharmaceutical composition containing galanthamine
NZ271363A (en) Use of antiglucocorticoid steroids to treat anxiety disorders
MY137435A (en) Retinoid compounds (i)
ATE381533T1 (de) Pharmazeutisch wirksame verbindungen und methoden zu ihrer anwendung
NZ333232A (en) Use of p-aminophenol derivatives (paracetamol) to treat neurodegenerative disease
MX9601994A (es) Profarmacos de derivados de paclitaxel.
IL137727A0 (en) Pharmaceutical preparations for supplementing oestrogen deficiency
FR2729295B1 (xx)
GR3025872T3 (en) Orally active derivatives of 1,3,5(10)-estratriene
WO2001085165A3 (de) Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems
AU8624198A (en) 11beta-aryl substituted 14,17-ethano-oestratriens, method for the production of these compounds and their use in the production of medicaments.
CA2421302A1 (en) 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
MX9800697A (es) Uso de glicosidos de calendula para el tratamiento de psoriasis.
UA10259A (uk) Протинабряковий лікарський препарат "нейрополіосм"